edoc

Items where contributor is "Moll, Jens"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping

Erb, Thomas O. and von Ungern-Sternberg, Britta S. and Moll, Jens and Frei, Franz J.. (2017) Reply to Baines, David, regarding their comment 'Comment on Erb TO, von Ungern-Sternberg BS, Moll J, Frei FJ. Impact of high concentrations of sevoflurane on laryngeal reflex responses'. Paediatric Anaesthesia, 27 (8). pp. 865-866.

Erb, Thomas O. and von Ungern-Sternberg, Britta S. and Moll, Jens and Frei, Franz J.. (2017) Impact of high concentrations of sevoflurane on laryngeal reflex responses. Paediatric Anaesthesia, 27 (3). pp. 282-289.

Moll, Jens and Kaufmann, Mark. (2016) Anesthesia for ophthalmic surgery. Therapeutische Umschau, 73 (2). pp. 61-66.

Pathippallil, Johnson and Wolff, Thomas and Aschwanden, Markus and Siegemund, Martin and Moll, Jens. (2 December 2015) Hypertonie in der Schwangerschaft; oder die Dinge sind nicht immer das, was sie zu sein scheinen. Swiss medical forum = Schweizerisches Medizin-Forum, 15 (49). pp. 1162-1164. Muttenz.

Moll, Jens and Erb, Thomas O. and Frei, Franz J.. (2015) Assessment of three placement techniques for individualized positioning of the tip of the tracheal tube in children under the age of 4 years. Paediatric Anaesthesia, 25 (4). pp. 379-385.

Erb, Thomas O. and Frei, Franz J. and Moll, Jens. (2012) The anesthesiologist's role assessing the individual patient's risk/benefit. Anesthesia and Analgesia, 114 (2). p. 476.

Brendebach, Luca and Siegemund, Martin and Moll, Jens and Pargger, Hans. (1 May 2011) 93-tägige Novalung-Therapie bei durch Influenza-A(H1N1) ausgelöstem ARDS. Swiss Medical Forum, 11 (18). pp. 319-321. Muttenz.

Reichenberg, Armin and Hintz, Martin and Kletschek, Yvonne and Kuhl, Tanja and Haug, Christian and Engel, Rosel and Moll, Jens and Ostrovsky, Dmitry N. and Jomaa, Hassan and Eberl, Matthias. (2003) Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T cells but does not lead to competitive antagonism. Bioorganic and Medicinal Chemistry Letters, 13 (7). pp. 1257-1260.

Altincicek, B. and Moll, J. and Campos, N. and Foerster, G. and Beck, E. and Hoeffler, J. F. and Grosdemange-Billiard, C. and Rodríguez-Concepción, M. and Rohmer, M. and Boronat, A. and Eberl, M. and Jomaa, H.. (2001) Cutting edge: human gamma delta T cells are activated by intermediates of the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. Journal of Immunology, 166 (6). pp. 3655-3658.